FOCUS: THIS WEEK'S TOP STORIES
Gauteng’s 3rd Wave: Crippled public hospitals put ’severe strain’ on private facilities
June 16th, 2021 With a key hospital shuttered and others crippled by recurrent water shortages, Gauteng is struggling to handle its largest wave of COVID-19 yet, reports MedicalBrief. Private hospitals in the province are under “severe strain” and...
Oops! So sorry about that, Zantac…
June 16th, 2021 An influential study linking a popular heartburn drug to cancer has been retracted after the authors concluded that their finding was a testing error, writes MedicalBrief. Marketed here as Zantac, Ultak, Ranihexal, and Ranitidine, the medicine was...SPONSORED EDITORIAL
How marijuana use affects your insurance
June 15th, 2021 Since many countries, South Africa included, decriminalised, through the Cannabis for Private Purposes Bill, the private use and growing of cannabis, its recreational use is increasing. This has significant insurance implications, writes Hugo du...JOB VACANCIES
Private practice opportunity for a Specialist Anaesthetist
June 16th, 2021 Organisation: Life Midmed Hospital Position: Specialist Anaesthetist – private practice opportunity for permanent position Deadline Date: 31/07/2021 Location: Life Midmed Hospital, Middelburg,...
Consulting Cardiologist - Hibiscus Hospital
June 16th, 2021 Hibiscus Hospital is a growing independently owned private hospital Group. Established in 1990 from humble beginnings, we have situated in Port Shepstone a multi-disciplinary acute 170 bed with 4 theatres (Inclusive of a 20 day beds and 2 theatres),...
Senior Research Officer
June 2nd, 2021 The Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) based at the Institute of Infectious Diseases and Molecular Medicine (IDM) in the Faculty of Health Sciences at the University of Cape Town is a multidisciplinary...
WEEKLY ROUNDUP
President Ramaphosa’s new COVID-19 restrictions to curb third wave
Full text of President Cyril Ramaphosa’s address to the nation on 15 June 2021, announcing new... June 16th, 2021Only 1% of hospital beds in England now have COVID-19 patients
Sir Simon Stevens, head of the National Health Service (NHS), says hospitals are in a “much... June 16th, 20216 die after 37 of 40 people on Namibia bus tour test positive for COVID-19
Six elderly tourists died from Covid-19 after 37 out of 40 travellers on a bus trip in Namibia... June 16th, 2021Feeling down, Down Under: Australian doctors’ launch online depression tool
An Australian network of privately practising mental health professionals has built and launched an... June 16th, 2021NEWS RELEASES
MSF: Governments off track on providing tools to prevent TB
As the World Health Organization (WHO) convenes a ‘call to action' this week on the need to scale... June 16th, 2021EFF: SAHPRA refusal to allow Sinovac and Sputnik condemned
The Economic Freedom Fighters (EFF) condemns the South African Health Products Regulatory Authority... June 16th, 2021DA: Parliamentary inquiry proposed into vaccine programme delays
The DA proposes the establishment of a parliamentary ad hoc committee to conduct a full inquiry... June 16th, 2021CORONAVIRUS
Regeneron treatment cuts COVID-19 mortality by 20% — RECOVERY trial
The world‘s largest trial of COVID-19 therapeutics has provided the first convincing evidence that a therapy that directly attacks the virus can save hospitalised patients from death, reports MedicalBrief. UK’s RECOVERY trial announced that a...
June 16th, 2021
DENTISTRY
Dental workers found to be at increased COVID-19 risk — UK study
UK dental professionals were at heightened occupational risk for COVID-19 infection early in the COVID-19 pandemic, according to an observational study yesterday in the Journal of Dental Research. The study also showed that the first dose of the... June 16th, 2021ONCOLOGY
‘Potential new standard’ in high-risk kidney cancer — KEYNOTE-564 trial
Single-agent immune checkpoint inhibition after surgery reduced the risk of disease recurrence or death in patients with high-risk clear cell renal cell carcinoma (RCC), findings from a phase III study present at the American Society of Clinical...
June 16th, 2021
PSYCHOLOGY
‘Laughing gas’ has rapid, lasting antidepressant effect — Phase II trial
The anaesthetic drug nitrous oxide - otherwise known as laughing gas - can significantly improve symptoms in people with treatment-resistant depression, found a University of Chicago Phase II clinical trial.
A single, one-hour treatment that...
June 16th, 2021
